# Mesa Laboratories (MLAB) — Earnings

MLAB · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/mlab/earnings

## Most recent quarter

| Metric | Value |
| --- | --- |
| Fiscal period | Q1 2027 |
| Period end | Jun 30, 2026 |
| EPS actual | $2.68 |
| EPS estimate | $2.63 |
| EPS surprise | +2.10% |
| Revenue surprise | −1.20% |
| Revenue | $60.1M |
| Revenue estimate | $60.9M |
| Reported | Aug 10, 2026 |
| SEC filing | [View filing](https://www.sec.gov:443/Archives/edgar/data/724004/000143774926026808/mlab20260630_10q.htm) |
| Earnings call | [Transcript](http://o.thsi.cn/dc-d-stock-america.teleconference/23bd3eed-fd0c-1d6c-fec4-d61307d96a42.html) |

Mesa Labs reported fiscal Q1 2027 results on August 10, 2026. Earnings per share were $2.68, 2.10% above the $2.63 estimate and up about 15% from $2.32 in fiscal Q1 2026. Revenue of $60.1 million came in 1.20% below the $60.9 million consensus and about 1% above the $59.5 million of a year earlier.

Annual EPS has risen every year in the table: $7.79 in fiscal 2023, $8.47 in 2024, $10.42 in 2025 and $11.44 in 2026. Fiscal 2026 revenue was $249.0 million, about 3% more than fiscal 2025's $240.9 million. The table's EPS high is $3.30 in fiscal Q4 2026, and its revenue high is $65.1 million in fiscal Q3 2026. Mesa Labs beat the EPS estimate in 18 of the last 20 quarters, often by wide margins; the largest beat was 137.37% in fiscal Q2 2023. The two misses were fiscal Q1 2023 and fiscal Q4 2025.

Fiscal Q2 results came out between November 3 and November 7 in each of the past five years. That points to early November 2026 for the next report. It will show how fiscal Q2 2027 compares with the $2.75 per share of fiscal Q2 2026.

## Earnings history

| Fiscal period | Report date | EPS estimate | EPS actual | Surprise | Revenue estimate | Revenue actual |
| --- | --- | --- | --- | --- | --- | --- |
| Q1 2027 | Aug 10, 2026 | $2.63 | $2.68 | 2.10% | $60.9M | $60.1M |
| Q4 2026 | May 27, 2026 | $2.09 | $3.30 | 58.27% | $65.2M | $63.7M |
| Q3 2026 | Feb 3, 2026 | $1.40 | $3.07 | 119.29% | $63.2M | $65.1M |
| Q2 2026 | Nov 6, 2025 | $1.62 | $2.75 | 70.10% | $60.7M | $60.7M |
| Q1 2026 | Aug 5, 2025 | $2.27 | $2.32 | 2.20% | $60.6M | $59.5M |
| Q4 2025 | May 28, 2025 | $2.29 | $2.25 | -1.89% | $61.9M | $62.1M |
| Q3 2025 | Feb 4, 2025 | $1.72 | $2.72 | 58.06% | $58.8M | $62.8M |
| Q2 2025 | Nov 7, 2024 | $1.89 | $2.62 | 38.62% | $57.9M | $57.8M |
| Q1 2025 | Aug 5, 2024 | $1.77 | $2.83 | 59.89% | $55.7M | $58.2M |
| Q4 2024 | Jun 5, 2024 | $1.91 | $2.77 | 45.28% | $55.3M | $58.9M |
| Q3 2024 | Feb 5, 2024 | $1.79 | $2.02 | 13.06% | $54.9M | $53.5M |
| Q2 2024 | Nov 6, 2023 | $1.79 | $1.91 | 6.90% | $55.4M | $53.2M |
| Q1 2024 | Aug 3, 2023 | $0.86 | $1.77 | 105.81% | $51.6M | $50.6M |
| Q4 2023 | May 25, 2023 | $1.69 | $1.94 | 15.07% | $58.1M | $55.6M |
| Q3 2023 | Feb 6, 2023 | $1.59 | $1.80 | 13.38% | $57.0M | $54.3M |
| Q2 2023 | Nov 3, 2022 | $1.21 | $2.88 | 137.37% | $53.2M | $58.7M |
| Q1 2023 | Aug 4, 2022 | $1.48 | $1.17 | -20.68% | $52.2M | $50.5M |
| Q4 2022 | May 31, 2022 | $1.80 | $2.22 | 23.44% | $56.4M | $58.9M |
| Q3 2022 | Feb 3, 2022 | $1.29 | $1.36 | 5.70% | $48.1M | $54.7M |
| Q2 2022 | Nov 4, 2021 | $1.07 | $1.87 | 75.59% | $35.2M | $35.8M |

## Frequently Asked Questions

### When did Mesa Laboratories (MLAB) last report earnings?

Mesa Laboratories last reported on Aug 10, 2026, covering fiscal Q1 2027.

### Did MLAB beat earnings estimates?

Yes. Mesa Laboratories reported EPS of $2.68 for Q1 2027 against a $2.63 estimate — a 2.10% beat.

### How much revenue did MLAB report last quarter?

Mesa Laboratories reported $60.1M in revenue for Q1 2027, against a consensus estimate of $60.9M.

---

Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).